Analysis of clinical features of 153 patients with novel coronavirus pneumonia in Chongqing/ 中华临床感染病杂志

Q4 Medicine
Qiuhua Wan, A. Shi, Ting He, Li-xin Tang
{"title":"Analysis of clinical features of 153 patients with novel coronavirus pneumonia in Chongqing/ 中华临床感染病杂志","authors":"Qiuhua Wan, A. Shi, Ting He, Li-xin Tang","doi":"10.3760/CMA.J.CN115673-20200212-00030","DOIUrl":null,"url":null,"abstract":"Objective \nTo analyze the clinical data of 153 patients with novel coronavirus pneumonia (COVID-19) in chongqing ,and provide reference and thinking for the diagnosis and treatment. \n \n \nMethods \nAnalyze the clinical data, laboratory examination and chest imaging characteristics of 153 COVID-19 patients in Chongqing Public Health Medical Center from January 26 to February 5, 2020. According to the relevant diagnostic criteria ,patients were divided into non-severe group(n=132) and severe group(n=21),and analyze the correlation between serum index changes and disease severity. \n \n \nResults \nCombined with diabetes and chronic respiratory diseases, the severity of the disease was statistically significant (χ2=11.04和6.94, P<0.05). No symptoms were found in patients with mild illness (χ2=4.09, P<0.05) .The proportion of fever and muscle soreness in the severe group was higher than that in the non-severe group (χ2=4.40 and 22.67,P<0.05).Among the concomitant symptoms, the proportion of cough and shortness of breath in the severe group was higher than that in the non-severe group (χ2=8.46 and 4.80,P<0.05).C-reactive protein and d-dimer were higher in the severe group than in the non-severe group (t=43.44 and 37.13, P<0.05), and the number of CD3+T lymphocyte cells, CD4+T lymphocyte cells and CD8+T lymphocyte cells in the severe group was lower than that in the non-severe group (Z=27.25, 20.60 and 17.36, P<0.05).Compared with the non-severe group, both lungs and the right lung lower lobe were more susceptible to involved (χ2=6.95和20.39, P<0.05) . \n \n \nConclusion \nSeverity of COVID-19 was associated with underlying disease, symptoms, site of involvement, C-reactive protein, d-dimer, CD3+T lymphocyte count, CD4+T lymphocyte count, and CD8+T lymphocyte count. \n \n \nKey words: \n2019 novel Coronavirus; Clinical features; Severe disease","PeriodicalId":52394,"journal":{"name":"中华临床感染病杂志","volume":"13 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"14","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华临床感染病杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.CN115673-20200212-00030","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 14

Abstract

Objective To analyze the clinical data of 153 patients with novel coronavirus pneumonia (COVID-19) in chongqing ,and provide reference and thinking for the diagnosis and treatment. Methods Analyze the clinical data, laboratory examination and chest imaging characteristics of 153 COVID-19 patients in Chongqing Public Health Medical Center from January 26 to February 5, 2020. According to the relevant diagnostic criteria ,patients were divided into non-severe group(n=132) and severe group(n=21),and analyze the correlation between serum index changes and disease severity. Results Combined with diabetes and chronic respiratory diseases, the severity of the disease was statistically significant (χ2=11.04和6.94, P<0.05). No symptoms were found in patients with mild illness (χ2=4.09, P<0.05) .The proportion of fever and muscle soreness in the severe group was higher than that in the non-severe group (χ2=4.40 and 22.67,P<0.05).Among the concomitant symptoms, the proportion of cough and shortness of breath in the severe group was higher than that in the non-severe group (χ2=8.46 and 4.80,P<0.05).C-reactive protein and d-dimer were higher in the severe group than in the non-severe group (t=43.44 and 37.13, P<0.05), and the number of CD3+T lymphocyte cells, CD4+T lymphocyte cells and CD8+T lymphocyte cells in the severe group was lower than that in the non-severe group (Z=27.25, 20.60 and 17.36, P<0.05).Compared with the non-severe group, both lungs and the right lung lower lobe were more susceptible to involved (χ2=6.95和20.39, P<0.05) . Conclusion Severity of COVID-19 was associated with underlying disease, symptoms, site of involvement, C-reactive protein, d-dimer, CD3+T lymphocyte count, CD4+T lymphocyte count, and CD8+T lymphocyte count. Key words: 2019 novel Coronavirus; Clinical features; Severe disease
Analysis of clinical features of 153 patients with novel coronavirus pneumonia in Chongqing/ 中华临床感染病杂志
目的分析重庆市153例新型冠状病毒肺炎(COVID-19)患者的临床资料,为诊断和治疗提供参考和思考。方法对2020年1月26日至2月5日在重庆市公共卫生医疗中心收治的153例新冠肺炎患者的临床资料、实验室检查及胸部影像学特征进行分析。根据相关诊断标准将患者分为非重度组(n=132)和重度组(n=21),分析血清指标变化与疾病严重程度的相关性。结果合并糖尿病、慢性呼吸系统疾病患者病情严重程度差异有统计学意义(χ2=11.04 ~ 6.94, P<0.05)。轻症患者无症状(χ2=4.09, P<0.05),重症组发热、肌肉酸痛比例高于非重症组(χ2=4.40、22.67,P<0.05)。中伴随的症状,咳嗽和气短的比例严重组高于不重的组(χ2 = 8.46,4.80,P < 0.05) .C-reactive蛋白质和肺动脉栓塞严重组高于不重的组(t = 43.44, 37.13, P < 0.05),细胞CD3 + t淋巴细胞的数量,CD4 + t淋巴细胞细胞和CD8 + t淋巴细胞细胞严重组低于不重的组(Z = 27.25, 20.60, 17.36, P < 0.05)。与非重症组相比,双肺及右肺下叶易感受累(χ2=6.95 ~ 20.39, P<0.05)。结论COVID-19严重程度与基础疾病、症状、受累部位、c反应蛋白、d-二聚体、CD3+T淋巴细胞计数、CD4+T淋巴细胞计数、CD8+T淋巴细胞计数有关。关键词:2019新型冠状病毒;临床特征;严重的疾病
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
中华临床感染病杂志
中华临床感染病杂志 Medicine-Infectious Diseases
CiteScore
0.70
自引率
0.00%
发文量
1445
期刊介绍: Chinese Journal of Clinical Infectious Diseases started its publication in April 2008. It had been indexed by CSTPCD of Institute of Scientific and Technical Information of China(ISTIC), Chinese Science Citation Database (CSCD), American Chemical Abstract (CA),Western Pacific Region Index Medicus(WPRIM), CNKI, Wanfang Data, Statistical Journal of China Academic Journal Impact Factor Annual Report,etc. The highest impact factor was 1.359, and the comprehensive quality of the journal ranked second in the field of infectious diseases in 2017. The article has been selected as one hundred excellent papers of Chinese medicine in 2018 and 2020, respectively. The journal is available both in print and online.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信